🔎 Trials Near Me

Início › Câncer de Pulmão de Células Pequenas › New Jersey

Ensaios clínicos de Câncer de Pulmão de Células Pequenas em New Jersey

17 estudos para Câncer de Pulmão de Células Pequenas estão buscando participantes em locais em New Jersey.

Cidades em New Jersey

Texto oficial do estudo (Inglês)

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • John Theurer Cancer Center at Hackensack UMC, Hackensack
RecrutandoFase 1
Idades 19 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06586957

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

  • MSK Basking Ridge, Basking Ridge
  • MSK Monmouth, Middletown
  • MSK Bergen., Montvale
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07476287

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Inspira Medical Center Mullica Hill /ID# 280574, Mullica Hill
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07365241

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

  • United Theranostics, Princeton
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07278479

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  • Hackensack University Medical Center, Hackensack
  • Rutgers Cancer Institute of New Jersey, New Brunswick
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07488676

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  • Astera Cancer Care, East Brunswick
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07625644

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06780137

A Study of Armored CAR T Cells in People With Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07783477

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

  • Morristown Medical Center, Morristown
  • Rutgers Cancer Institute, New Brunswick
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT07057791

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

  • Regional Cancer Care Associates, Belleville
  • John Theurer Cancer Center at Hackensack UMC, Hackensack
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06892548

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

  • Hackensack University Medical Center, Hackensack
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT07488923

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06807632

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  • Astera Cancer Care, East Brunswick
  • Hackensack Meridian Health Jsumc, Neptune City
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT06203210

A Study of LY4175408 in Participants With Advanced Cancer

  • John Theurer Cancer Center At Hackensack UMC, Hackensack
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT07046923

A Study of Hospital-at-Home for People Receiving Tarlatamab

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT06957314

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

  • Memorial Sloan Kettering at Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT05419076

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Englewood Hospital and Medical Center (site 202), Englewood
  • Summit Medical Group (site 205), Florham Park
  • Atlantic Health System, Morristown Medical Center (site 124), Morristown
RecrutandoFase 1/2
Idades de 18 a 80 · Todos os sexos · Atualizado em 11 de dez. de 2025 · NCT03556228

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.